Gemcitabine plus enzastaurin or single-agent gemcitabine in locally advanced or metastatic pancreatic cancer: Results of a Phase II, randomized, noncomparative study
Richards, Donald A., Kuefler, Paul R., Becerra, Carlos, Wilfong, Lalan S., Gersh, Robert H., Boehm, Kristi A., Zhan, Feng, Asmar, Lina, Myrand, Scott P., Hozak, Rebecca R., Zhao, Luping, Gill, John F., Mullaney, Brian P., Obasaju, Coleman K., Nicol, Steven J.
Published in Investigational new drugs (01.02.2011)
Published in Investigational new drugs (01.02.2011)
Get full text
Journal Article
Results of a phase II study of pemetrexed as first-line chemotherapy in patients with advanced or metastatic breast cancer
Robert, Nicholas J, Conkling, Paul R, O'Rourke, Mark A, Kuefler, Paul R, McIntyre, Kristi J, Zhan, Feng, Asmar, Lina, Wang, Yanping, Shonukan, Oluwatoyin O, O'Shaughnessy, Joyce A
Published in Breast cancer research and treatment (01.02.2011)
Published in Breast cancer research and treatment (01.02.2011)
Get full text
Journal Article
Gemcitabine plus enzastaurin or single-agent gemcitabine in locally advanced or metastatic pancreatic cancer: Results of a Phase II, randomized, noncomparative study
Richards, Donald A., Kuefler, Paul R., Becerra, Carlos, Wilfong, Lalan S., Gersh, Robert H., Boehm, Kristi A., Zhan, Feng, Asmar, Lina, Myrand, Scott P., Hozak, Rebecca R., Zhao, Luping, Gill, John F., Mullaney, Brian P., Obasaju, Coleman K., Nicol, Steven J.
Published in Investigational new drugs (01.02.2011)
Published in Investigational new drugs (01.02.2011)
Get full text
Journal Article